These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 867315)

  • 1. [Inhibition of platelet function (mode of action of platelet inhibitors) (author's transl)].
    Baumgartner HR
    Ther Umsch; 1977 May; 34(5):341-6. PubMed ID: 867315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet aggregation from interaction between washed platelets and purified thrombin, plasmin or trypsin (author's transl)].
    Matsuoka M; Watanabe T; Koike K; Sakuragawa N
    Rinsho Ketsueki; 1974 May; 15(5):519-23. PubMed ID: 4277899
    [No Abstract]   [Full Text] [Related]  

  • 3. [Platelet research method and its application in the study of "huo xuo hua yu"].
    Wang Z
    Zhong Xi Yi Jie He Za Zhi; 1984 Aug; 4(8):501-4. PubMed ID: 6238720
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic agents, pharmacologic principles].
    Markwardt F
    Z Arztl Fortbild (Jena); 1986; 80(14):565-70. PubMed ID: 3765695
    [No Abstract]   [Full Text] [Related]  

  • 5. [Platelet aggregation increase. An unexpected result in fibrinolytic therapy].
    Griguer P
    Ann Cardiol Angeiol (Paris); 1973; 22(3):223-30. PubMed ID: 4731540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibition of platelet aggregation and its clinical use (author's transl)].
    Cepelák V
    Cas Lek Cesk; 1974 Jan; 113(2):51-5. PubMed ID: 4154807
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of platelet aggregation under estrogen-treatment in patients with carcinoma of the prostate (author's transl)].
    Eisen M; Napp HE; Vock R
    Urologe A; 1975 May; 14(3):132-6. PubMed ID: 1154559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet function with bencyclane.
    Bédi J; Pálos AL
    Ther Hung; 1976; 24(2):50-5. PubMed ID: 982339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of elastase on platelet adhesiveness and platelet aggregation (author's transl)].
    Kobayashi T; Sakaki H; Toyoshima H; Fujita S; Uesugi S; Endo Y; Satoh M
    Rinsho Byori; 1981 Mar; 29(3):295-8. PubMed ID: 6911161
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of platelet function by antithrombotic agents which selectively inhibit low-Km cyclic 3',5'-adenosine monophosphate phosphodiesterase.
    Tang SS; Frojmovic MM
    J Lab Clin Med; 1980 Feb; 95(2):241-57. PubMed ID: 6243686
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cyclonamine on blood platelets. II. Changes in the surface charge and inhibition of the release reaction.
    Sack ES; Cerutti N
    Medicina (B Aires); 1973; 3(6):685-94. PubMed ID: 4805048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Substances decreasing the aggregation and adhesiveness of thrombocytes (review of the literature)].
    Lakin KM; Fel'dbaum VA; Lebedeva AA
    Farmakol Toksikol; 1971; 34(1):104-13. PubMed ID: 4397898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on fibrinolytic agent-platelet interaction (author's transl)].
    Mishina Y; Watada M
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):154-60. PubMed ID: 4277931
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of salicylic acid and pyridinolcarbamate on the platelet aggregation (author's transl)].
    Altman R; Rouvier J; Taboada S; Mosquera G
    Sangre (Barc); 1974; 19(4):385-98. PubMed ID: 4445961
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-acting fibrinolytic drugs. Drugs acting on platelet aggregation].
    de Nicola P
    Angeiologie; 1967; 20():Suppl:45-53. PubMed ID: 5621507
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.